Top in cardiology: NSAIDs after MI, bariatric surgery and CV events

Researchers found the use of NSAIDs after a myocardial infarction posed a greater risk for cardiovascular and bleeding events. It was the top story in cardiology last week.

Another top story was about a study that showed bariatric surgery was associated with a reduction in major cardiovascular (CV) events.

Read these and more top stories in cardiology below:

NSAIDs increase risk for events after MI

The use of NSAIDs after a myocardial infarction significantly increased the risk for CV and bleeding events, researchers found. Read more.

Bariatric surgery demonstrates good long-term CV outcomes

Bariatric surgery demonstrated significant long-term benefits for the reduction of major adverse CV events and incident heart failure, according to a study published in the European Heart Journal. Read more.

Alirocumab lowers major adverse CV event risk in ACS irrespective of statin intensity

Alirocumab (Praluent, Sanofi/Regeneron) reduced the relative risk for major adverse CV events in patients after acute coronary syndrome regardless of background statin treatment, researchers found in the ODYSSEY OUTCOMES trial. Read more.

New program teaches people with disabilities how to advise on use of CPR, AEDs

The American Heart Association announced the development of a program to teach individuals with physical disabilities who may not be able to perform cardiopulmonary resuscitation themselves how to instruct others in an emergency. Read more.

Valve-in-valve TAVR confers short-term benefits in failed surgical AVR

Among patients with a failed surgical aortic valve, valve-in-valve transcatheter aortic valve replacement was linked to better short-term outcomes than redo surgical AVR, researchers reported. Read more.